Overview

A Study in Healthy Men and Women to Test Which Effects Memantine and BI 425809 Have on Each Other

Status:
Completed
Trial end date:
2019-10-30
Target enrollment:
Participant gender:
Summary
Investigate the effect of steady state exposures of memantine on the steady-state pharmacokinetics of BI 425809 and vice versa in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
BI 425809
Memantine